Conestat alfa and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Conestat alfa and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: conestat alfa
Brand name: Ruconest
Synonyms: C1 Inhibitor (Recombinant)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Conestat alfa-Insulin degludec
- Conestat alfa-Insulin Degludec (U-100) Prefilled Pens
- Conestat alfa-Insulin Degludec (U-100) Vials
- Conestat alfa-Insulin Degludec (U-200) Prefilled Pens
- Conestat alfa-Insulin degludec and liraglutide
- Conestat alfa-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Conex
- Insulin aspart, recombinant Subcutaneous-Conex Cold/Allergy
- Insulin aspart, recombinant Subcutaneous-Congestion Relief
- Insulin aspart, recombinant Subcutaneous-Conivaptan
- Insulin aspart, recombinant Subcutaneous-Conivaptan Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Conivaptan Intravenous